gemcitabine has been researched along with EBV Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Cabezas-Camarero, S; Cabrera-Martín, MN; Pérez-Alfayate, R; Pérez-Segura, P; Puebla, F | 1 |
| Gauthier, M; Laurent, C; Mouchel, PL; Syrykh, C; Tavitian, S | 1 |
| Cai, X; Chao, H; Chen, M; Jiang, Y; Lu, X | 1 |
| Burns, G; Greystoke, A; Iqbal, MS; Robinson, M; Rodriguez, CN | 1 |
| de Greeuw, I; Eersels, JLH; Greijer, AE; Middeldorp, JM; Molthoff, CFM; Novalić, Z; Verkuijlen, SAWM; Verlaan, M | 1 |
| Gandara, DR; Knollmann, FD; Lim, S; Narayanan, A; Riess, JW; Walby, JAS | 1 |
| Chang, KP; Chang, YS; Fan, HC; Hsieh, CH; Hsu, CL; Huang, Y; Huang, YC; Kuo, YC; Lee, LY; Li, HP; Lin, AC; Lin, TL; Lui, KW; Wang, HM | 1 |
| Ambinder, RF; Chen, J; Choi, TH; Chong, CR; Dong, SM; Hayward, SD; Kim, EJ; Kim, H; Lee, HG; Lee, JM; Liu, JO; Park, JH; Park, PG | 1 |
| Cheah, SL; Chua, ML; Fong, KW; Kusumawidjaja, G; Shwe, MT; Soong, YL; Tan, SH; Tan, TW; Wee, JT | 1 |
| Agarwal, N; Agarwal, P; Baisre, A; Goldstein, IM; Hansberry, DR; Kavi, A | 1 |
| Balaraman, B; Conley, JA; Sheinbein, DM | 1 |
| Delecluse, HJ; Feng, WH; Hong, G; Kenney, SC | 1 |
| Arnaud, P; Bordier, V; Couturier, J; Decaudin, D; Lantz, O; Marszak, FB; Martin, A; Mathiot, C; Némati, F; Poupon, MF; Santo, Jd; Vincent-Salomon, A | 1 |
1 review(s) available for gemcitabine and EBV Infections
| Article | Year |
|---|---|
Evaluation of cutaneous angioimmunoblastic T-cell lymphoma.
Topics: Aged; Arthralgia; Cyclophosphamide; Deoxycytidine; Diphtheria Toxin; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Gene Rearrangement, T-Lymphocyte; Humans; Immunoblastic Lymphadenopathy; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Prednisolone; Pruritus; Recombinant Fusion Proteins; Retrospective Studies; Skin Neoplasms; Stem Cell Transplantation; Vinblastine; Vincristine; Vinorelbine | 2011 |
12 other study(ies) available for gemcitabine and EBV Infections
| Article | Year |
|---|---|
Increased clinical and plasma EBV DNA responses to platinum-gemcitabine after nivolumab in patients with heavily platinum-pretreated nasopharyngeal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; DNA, Viral; Epstein-Barr Virus Infections; Gemcitabine; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Nivolumab; Organoplatinum Compounds | 2020 |
First case of classical Hodgkin-like EBV-positive lymphoproliferative disorder under ruxolitinib therapy.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Deoxycytidine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Gemcitabine; Humans; Immunocompromised Host; Lymph Nodes; Lymphoproliferative Disorders; Male; Middle Aged; Nitriles; PAX5 Transcription Factor; Prednisone; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Reed-Sternberg Cells; RNA, Viral; Thrombocythemia, Essential; Vinblastine | 2021 |
Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Epstein-Barr Virus Infections; Gemcitabine; Herpesvirus 4, Human; Humans; Inhibitory Concentration 50; Lymphoma, Extranodal NK-T-Cell; Mice; Thymalfasin; Viral Load; Xenograft Model Antitumor Assays | 2021 |
[A Rare Case of Non-small Cell Lung Carcinoma Squamous Phenotype with Epstein-Barr Virus Positivity with Prolonged Response to both Chemotherapy and Radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Carboplatin; Carcinoma, Squamous Cell; Deoxycytidine; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Humans; Lung Neoplasms; Lupus Erythematosus, Systemic; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Radiotherapy; Tuberculosis, Pulmonary | 2021 |
Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.
Topics: Animals; Antiviral Agents; Carcinoma; Deoxycytidine; Disease Models, Animal; DNA, Viral; Epstein-Barr Virus Infections; Ganciclovir; Gemcitabine; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Treatment Outcome; Tumor Cells, Cultured; Valproic Acid; Viral Load; Virus Activation | 2017 |
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade.
Topics: Adenocarcinoma of Lung; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Deoxycytidine; Docetaxel; Drug Resistance; Drug Substitution; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Humans; Immunotherapy; Lung Neoplasms; Neoplasm Staging; Treatment Outcome | 2019 |
Application of a patient-derived xenograft model in cytolytic viral activation therapy for nasopharyngeal carcinoma.
Topics: Animals; Anticonvulsants; Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Carcinoma; Cell Proliferation; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; Gemcitabine; Gene Expression Profiling; Herpesvirus 4, Human; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Inbred NOD; Mice, SCID; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Oncolytic Virotherapy; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Valproic Acid; Viral Load; Virus Activation; Xenograft Model Antitumor Assays | 2015 |
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Drug Repositioning; Enzyme Induction; Epstein-Barr Virus Infections; Female; Ganciclovir; Gemcitabine; Herpesvirus 4, Human; Humans; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Protein Kinases; RNA Interference; Signal Transduction; Stomach Neoplasms; Thymidine Kinase; Time Factors; Transfection; Tumor Burden; Viral Proteins; Virus Activation; Xenograft Model Antitumor Assays | 2015 |
Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorouracil; Gemcitabine; Herpesvirus 4, Human; Humans; Leukocyte Count; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutrophils; Prognosis; Proportional Hazards Models; Radiotherapy; Randomized Controlled Trials as Topic; Singapore; Survival Rate | 2016 |
Prognostic Differences: Epstein-Barr Virus-Associated Primary Leiomyosarcoma of the Spine Versus Spinal Leiomyosarcoma Metastases.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Docetaxel; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Humans; Immunocompromised Host; Leiomyosarcoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Prognosis; Retroperitoneal Neoplasms; Spinal Neoplasms; Taxoids | 2017 |
Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.
Topics: Animals; Antibiotics, Antineoplastic; Antiviral Agents; B-Lymphocytes; Cell Line, Transformed; Deoxycytidine; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; Gemcitabine; Herpesvirus 4, Human; Humans; Lymphoma, B-Cell; Mice; Mice, SCID; Signal Transduction; Tumor Cells, Cultured; Virus Activation | 2004 |
High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.
Topics: Adult; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Deoxycytidine; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Hodgkin Disease; Homeodomain Proteins; Humans; Immunoglobulin Heavy Chains; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Mice, Knockout; Mice, SCID; Nucleic Acid Hybridization; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |